Admedus is a structural heart company delivering
clinically superior solutions to help healthcare professionals to
create life-changing outcomes for patients.

Our Technology

Our proprietary ADAPT engineering process
produces implantable tissue bio-scaffolds for a range of cardiovascular and vascular applications.


Clinically superior solutions that last a lifetime


Positive Data on CardioCel® Published In Leading Journal
A link to purchase a copy of the manuscript can be found here
Read more.
Annual General Meeting
Our CEO Wayne Paterson presenting on the vision for Admedus at this years Annual General Meeting in Brisbane, Australia. To...
Read more.

Great Interview with with Mr. Tomasz Mroczek (Kraków, Poland) where he explains the management of critically ill in…
Read the article below from Cardiovascular News showing the findings on trans-catheter aortic valve implantation in…
Performance of the ADAPT-Treated CardioCel® Bio Scaffold in Pediatric Patients with Congenital Cardiac Anomalies: M…
Dr. Alan Zajarias discusses the advancements in tissue technology in #TAVR specifically with #ADAPT at the Cardiova…
Interventional Cardiologist Dr. Paul Sorajja gave the companies first podium presentation on our #TAVR at the 2019…